Masakatsu Nagai - Böcker
Visar alla böcker från författaren Masakatsu Nagai. Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
552 kr
Skickas inom 10-15 vardagar
The title of this monograph, Brain Tumor Research and Therapy, is the name of the Conference itself, which had its inaugural meeting in the United States in 1975 andhas since progressed to the international scale. In Japan, the first conference ofits kind was organized by Dr. Takao Hoshino and me and was held at Nikko in 1980, hence its name, the Nikko Conference on Brain Tumor Research and Therapy. Though it started as a small, closed meeting, the conference has grown considerably, and in 1992 it was reorganized as the Japanese Conference on Brain Tumor Research and Therapy and was opened to all neurosurgeons and neuropathologists interested in the study of brain tumor problems and who are participating in this field. The main purpose of the Conference on Brain Tumor Research and Therapy is the candid and informed discussion of the most up-to-date developments in basic re search and clinical treatment of brain tumors. The 3rd Japanese Conference on Brain Tumor Research and Therapy was held at Nasu (Tochigi Prefecture), Japan, in No vember 1994. It was a great honor to welcome many distinguished guests from over seas who kindly attended each session and made valuable contributions.
552 kr
Skickas inom 10-15 vardagar
This volume provides up-to-date results of both fundamental and clinical studies covering a broad area of tumour research. The book comprises 46 papers specially selected from the lectures and presentations delivered at the 3rd Japanese Conference on Brain Tumor Research and Therapy. The book is divided into four parts on: a re-evaluation of brain tumour classification and grading; the dynamic aspects of brain tumour cells; molecular neurooncology and its impact on clinical management, and advances in novel therapeutic approaches, including biological response markers (BRM) and gene therapy. Findings are included from Japan, the US and Europe.